1. 2022
  2. A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques

    He, X., Aid, M., Chandrashekar, A., Yu, J., McMahan, K., Wegmann, F., Jacob-Dolan, C., Maron, J. S., Atyeo, C., Wan, H., Sellers, D., Liu, J., Lifton, M., Gardner, S., Bondzie, E. A., Barrett, J., Ahmad, K., Anioke, T., Yalley-Ogunro, J., Muench, J. & 7 others, Goode, A., Andersen, H., Lewis, M. G., Alter, G., Schuitemaker, H., Zahn, R. & Barouch, D. H., 30 Mar 2022, In: Science translational medicine. 14, 638, abm4996.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization

    Schorcht, A., Cottrell, C. A., Pugach, P., Ringe, R. P., Han, A. X., Allen, J. D., van den Kerkhof, T. L. G. M., Seabright, G. E., Schermer, E. E., Ketas, T. J., Burger, J. A., van Schooten, J., LaBranche, C. C., Ozorowski, G., de Val, N., Bader, D. L. V., Schuitemaker, H., Russell, C. A., Montefiori, D. C., van Gils, M. J. & 5 others, Crispin, M., Klasse, P. J., Ward, A. B., Moore, J. P. & Sanders, R. W., 1 Jan 2022, In: Journal of virology. 96, 1, e01552-21.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. 2020
  5. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers

    Schorcht, A., van den Kerkhof, T. L. G. M., Cottrell, C. A., Allen, J. D., Torres, J. L., Behrens, A-J., Schermer, E. E., Burger, J. A., de Taeye, S. W., Torrents de la Peña, A., Bontjer, I., Gumbs, S., Ozorowski, G., LaBranche, C. C., de Val, N., Yasmeen, A., Klasse, P. J., Montefiori, D. C., Moore, J. P., Schuitemaker, H. & 4 others, Crispin, M., van Gils, M. J., Ward, A. B. & Sanders, R. W., Dec 2020, In: Journal of virology. 94, 24, e01214-20.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

    Colby, D. J., Sarnecki, M., Barouch, D. H., Tipsuk, S., Stieh, D. J., Kroon, E., Schuetz, A., Intasan, J., Sacdalan, C., Pinyakorn, S., Grandin, P., Song, H., Tovanabutra, S., Shubin, Z., Kim, D., Paquin-Proulx, D., Eller, M. A., Thomas, R., de Souza, M., Wieczorek, L. & 14 others, Polonis, V. R., Pagliuzza, A., Chomont, N., Peter, L., Nkolola, J. P., Vingerhoets, J., Truyers, C., Pau, M. G., Schuitemaker, H., Phanuphak, N., Michael, N., Robb, M. L., Tomaka, F. L. & Ananworanich, J., 1 Apr 2020, In: Nature medicine. 26, 4, p. 498-501 4 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2019
  8. Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users

    Euler, Z., VAN DEN Kerkhof, T. L., Kouyos, R. D., Tully, D. C., Allen, T. M., Trkola, A., Sanders, R. W., Schuitemaker, H. & VAN Gils, M. J., 2019, In: Viruses. 11, 4

    Research output: Contribution to journalArticleAcademicpeer-review

  9. 2018
  10. Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response

    Vujadinovic, M., Wunderlich, K., Callendret, B., Koning, M., Vermeulen, M., Sanders, B., van der Helm, E., Gecgel, A., Spek, D., de Boer, K., Stalknecht, M., Serroyen, J., Grazia Pau, M., Schuitemaker, H., Zahn, R., Custers, J. & Vellinga, J., 2018, In: Human gene therapy. 29, 3, p. 337-351

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge

    Cox, F., van der Fits, L., Abbink, P., Larocca, R. A., van Huizen, E., Saeland, E., Verhagen, J., Peterson, R., Tolboom, J., Kaufmann, B., Schuitemaker, H., Barouch, D. H. & Zahn, R., 2018, In: PLoS ONE. 13, 8, e0202820.

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses

    Vujadinovic, M., Khan, S., Oosterhuis, K., Uil, T. G., Wunderlich, K., Damman, S., Boedhoe, S., Verwilligen, A., Knibbe, J., Serroyen, J., Schuitemaker, H., Zahn, R., Scheper, G., Custers, J. & Vellinga, J., 2018, In: Vaccine. 36, 30, p. 4462-4470

    Research output: Contribution to journalArticleAcademicpeer-review

  13. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model

    Bockstal, V., Tiemessen, M. M., Achterberg, R., van Wordragen, C., Knaapen, A. M., Serroyen, J., Marissen, W. E., Schuitemaker, H. & Zahn, R., 2018, In: Vaccine. 36, 46, p. 6979-6987

    Research output: Contribution to journalArticleAcademicpeer-review

  14. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

    Callendret, B., Vellinga, J., Wunderlich, K., Rodriguez, A., Steigerwald, R., Dirmeier, U., Cheminay, C., Volkmann, A., Brasel, T., Carrion, R., Giavedoni, L. D., Patterson, J. L., Mire, C. E., Geisbert, T. W., Hooper, J. W., Weijtens, M., Hartkoorn-Pasma, J., Custers, J., Pau, M. G., Schuitemaker, H. & 1 others, Zahn, R., 2018, In: PLoS ONE. 13, 2, e0192312.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...29 Next

ID: 84154